Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial
Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (World Health Organization, 2025).
World Obesity Atlas 2024. https://www.worldobesity.org/news/world-obesity-atlas-2024 (World Obesity Federation, 2024).
Boutari, C. & Mantzoros, C. S. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism 133, 155217 (2022).
Imes, C. C. & Burke, L. E. The obesity epidemic: the USA as a cautionary tale for the rest of the world. Curr. Epidemiol. Rep. 1, 82–88 (2014).
Okunogbe, A. et al. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob. Health 7, e009773 (2022).
Garvey, W. T. et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr. Pract. 22, 1–203 (2016).
Leibel, R. L. et al. Biologic responses to weight loss and weight regain: report from an American Diabetes Association research symposium. Diabetes 64, 2299–2309 (2015).
Wing, R. R. & Phelan, S. Long-term weight loss maintenance. Am. J. Clin. Nutr. 82, 222S–225S (2005).
Field, A., Wing, R., Manson, J., Spiegelman, D. & Willett, W. Relationship of a large weight loss to long-term weight change among young and middle-aged US women. Int. J. Obesity 25, 1113–1121 (2001).
Rosenbaum, M. & Foster, G. Differential mechanisms affecting weight loss and weight loss maintenance. Nat. Metab. 5, 1266–1274 (2023).
Van Baak, M. A. & Mariman, E. C. Mechanisms of weight regain after weight loss—the role of adipose tissue. Nat. Rev. Endocrinol. 15, 274–287 (2019).
Hinte, L. C. et al. Adipose tissue retains an epigenetic memory of obesity after weight loss. Nature 636, 457–465 (2024).
Wilding, J. P. et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes. Metab. 24, 1553–1564 (2022).
Berg, S., Stickle, H., Rose, S. J. & Nemec, E. C. Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis. Obes. Rev. 26, e13929 (2025).
Thaiss, C. A., Shapiro, H. & Elinav, E. Post-dieting weight gain: the role of persistent microbiome changes. Future Microbiol. 12, 555−559 (2017).
De Vos, W. M., Tilg, H., Van Hul, M. & Cani, P. D. Gut microbiome and health: mechanistic insights. Gut 71, 1020–1032 (2022).
Van Hul, M. et al. Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities. Clin. Microbiol. Rev. 37, e0004523 (2024).
Cani, P. D. Gut microbiota—at the intersection of everything? Nat. Rev. Gastroenterol. Hepatol. 14, 321–322 (2017).
Canfora, E. E., Meex, R. C. R., Venema, K. & Blaak, E. E. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat. Rev. Endocrinol. 15, 261–273 (2019).
Aburto, M. R. & Cryan, J. F. Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota–gut–brain axis. Nat. Rev. Gastroenterol. Hepatol. 21, 222–247 (2024).
De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84–96 (2014).
Derrien, M. et al. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front. Microbiol. 2, 166 (2011).
Iwaza, R., Wasfy, R. M., Dubourg, G., Raoult, D. & Lagier, J.-C. Akkermansia muciniphila: the state of the art, 18 years after its first discovery. Front. Gastroenterol. 1, 1024393 (2022).
Cani, P. D. & de Vos, W. M. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front. Microbiol. 8, 1765 (2017).
Cani, P. D., Depommier, C., Derrien, M., Everard, A. & de Vos, W. M. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat. Rev. Gastroenterol. Hepatol. 19, 625–637 (2022).
Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066–9071 (2013).
Ouwerkerk, J. P. et al. Comparative genomics and physiology of Akkermansia muciniphila isolates from human intestine reveal specialized mucosal adaptation. Microorganisms 10, 1605 (2022).
Liu, E., Ji, X. & Zhou, K. Akkermansia muciniphila for the prevention of type 2 diabetes and obesity: a meta-analysis of animal studies. Nutrients 16, 3440 (2024).
Segers, A. & de Vos, W. M. Mode of action of Akkermansia muciniphila in the intestinal dialogue: role of extracellular proteins, metabolites and cell envelope components. Microbiome Res. Rep. 2, 6 (2023).
Plovier, H. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107–113 (2017).
Qu, L. et al. Improvement in zebrafish with diabetes and Alzheimer’s disease treated with pasteurized Akkermansia muciniphila. Microbiol. Spectr. 11, e00849-23 (2023).
Li, J., Lin, S., Vanhoutte, P. M., Woo, C. W. & Xu, A. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe−/− mice. Circulation 133, 2434–2446 (2016).
Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096–1103 (2019).
Dao, M. C. et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426–436 (2016).
Magkos, F. et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 23, 591–601 (2016).
Depommier, C. et al. Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice. Gut Microbes 11, 1231–1245 (2020).
Misera, A., Marlicz, W., Podkówka, A., Łoniewski, I. & Skonieczna-Żydecka, K. Possible application of Akkermansia muciniphila in stress management. Microbiome Res. Rep. 3, 48 (2024).
Zhang, Y. et al. Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: efficacy depends on its baseline levels in the gut. Cell Metab. 37, 592–605 (2025).
Zhou, Q. et al. Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project. Nutr. Metab. (Lond.) 17, 9040 (2020).
Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).
Kromhout, D., Spaaij, C., de Goede, J. & Weggemans, R. The 2015 Dutch food-based dietary guidelines. Eur. J. Clin. Nutr. 70, 869–878 (2016).
Kulich, K. R. et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual. Life Outcomes 6, 12 (2008).
Wendel-Vos, G. W., Schuit, A. J., Saris, W. H. & Kromhout, D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J. Clin. Epidemiol. 56, 1163–1169 (2003).
Gijbels, A. et al. Hepatic insulin resistance and muscle insulin resistance are characterized by distinct postprandial plasma metabolite profiles: a cross-sectional study. Cardiovasc. Diabetol. 23, 97 (2024).
Orskov, C., Rabenhøj, L., Wettergren, A., Kofod, H. & Holst, J. J. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43, 535–539 (1994).
Han, J., Lin, K., Sequeira, C. & Borchers, C. H. An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography−tandem mass spectrometry. Anal. Chim. Acta 854, 86–94 (2015).
Lee, J. W. et al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23, 312–328 (2006).
Picarelli, A. et al. Quantitative analysis of stool losses in adult celiac disease: Use of near-infrared analysis reconsidered. Scand. J. Gastroenterol. 33, 1052–1056 (1998).
Knudsen, B. E. et al. Impact of sample type and DNA isolation procedure on genomic inference of microbiome composition. mSystems 1, e00095-16 (2016).
Jardon, K. M. et al. Distinct gut microbiota and metabolome features of tissue-specific insulin resistance in overweight and obesity. Gut Microbes 17, 2501185 (2025).
Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M. & Salminen, S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73, 7767–7770 (2007).
Lundgren, J. R. et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N. Engl. J. Med. 384, 1719–1730 (2021).
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J.17, 10–12 (2011).
Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852–857 (2019).
Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2012).
Bisanz, J. qiime2R: Importing QIIME2 artifacts and associated data into R sessions. GitHub https://github.com/jbisanz/qiime2R (2019).
McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).
Kembel, S. W. et al. Picante: R tools for integrating phylogenies and ecology. Bioinformatics 26, 1463–1464 (2010).
Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. lmerTest package: tests in linear mixed effects models. J. Stat. Softw. 82, 1–26 (2017).
Bates, D., Mächler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1–48 (2015).
Oksanen, J. et al. vegan: Community ecology package. CRAN https://cran.r-project.org/web/packages/vegan/index.html (2001).
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).
Paulson, J. N., Stine, O. C., Bravo, H. C. & Pop, M. Differential abundance analysis for microbial marker-gene surveys. Nat. Methods 10, 1200–1202 (2013).
Zhou, H., He, K., Chen, J. & Zhang, X. LinDA: linear models for differential abundance analysis of microbiome compositional data. Genome Biol. 23, 95 (2022).
